More than 50 million people in the world suffer from dementia or Alzheimer’s disease and it is estimated that 40% of cases can be prevented by adopting healthy lifestyle habits. Spanish Society of Neurology (Sen). Well, within the framework of World Brain Day, which is celebrated every 22 July, the pharma market has interviewed alvaro coral, To learn more about this, neuropsychologists from the Fundación Alzheimer’s Espaa (FAE) Neurodegenerative disease.
You can see the whole thing on our YouTube channel, the expert explains in the interview that, although age is one of the main factors in developing Alzheimer’s disease, “not necessarily all people will suffer from it as they get older”.
symptoms and lifestyle
Furthermore, it indicates that “it is true that aging is related to A. discrete memory loss And this fact becomes a barrier when it comes to distinguishing between normal aging and pathological aging and which would later be linked to Alzheimer’s”.
Although age is one of the main factors in the development of Alzheimer’s disease, “not necessarily all people will suffer from it as they get older.”
Neuropsychologists state that short term memory loss This is one of its main symptoms, along with language difficulties, changes in the cognitive plane such as attention or concentration problems. However, there are also manifestations related to the affective or behavioral plane that precede or accompany the disease.
Regarding the habits of life, lvaro Coral remarks that, on the one hand, it is known that there are a series of risk Related to life habits that may favor the appearance of this pathology. Similarly, on the other hand, it is known that suffering from depression or depressive symptoms two years before the onset of early symptoms of Alzheimer’s disease, especially in people over the age of 55, is a significant risk factor.
Suffering from depression or depressive symptoms two years before the onset of Alzheimer’s disease, especially in people over the age of 55, is a significant risk factor.
bran
The FAE spokesperson believes that it will certainly be necessary over time to conduct population screening in “age groups where we know there is a higher risk of disease onset, but there is no consensus on this. Maybe.” Is recommendation for the future,
in the same way, Explains that carrying out “a chain” clinical trial For some population groups this may be a way to identify people who may potentially develop the disease and thus initiate therapeutic plans as soon as possible. And he stresses that the goal in the end is to seek a diagnosis as soon as possible.
With regard to non-pharmacological interventions, Coral assures that they have come a long way and have “great therapeutic efficacy” when it comes to slowing disease progression.
refering to non-pharmacological interventionsCoral assures that they have come a long way and have “great therapeutic efficacy” when it comes to slowing disease progression.
Coordination among various health professionals to detect this neurological disorder is still a pending issue according to neuropsychologists. “We are better than we were 10 years ago but chances are it will take time More coordination on a global scale It should start with PC where it is necessary to provide resources to professionals and centers so that they are able to detect early symptoms. Also, communication towards neurology services should be coordinated in a more specific way.”
